Strs Ohio Makes New $1.08 Million Investment in Docusign Inc. $DOCU

Strs Ohio acquired a new position in shares of Docusign Inc. (NASDAQ:DOCU) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 13,290 shares of the company’s stock, valued at approximately $1,082,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Wealth Management Associates Inc. raised its holdings in shares of Docusign by 6.3% in the first quarter. Wealth Management Associates Inc. now owns 9,810 shares of the company’s stock valued at $799,000 after purchasing an additional 580 shares during the last quarter. Plato Investment Management Ltd raised its holdings in shares of Docusign by 3.8% in the first quarter. Plato Investment Management Ltd now owns 8,581 shares of the company’s stock valued at $706,000 after purchasing an additional 311 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Docusign by 18.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,028,505 shares of the company’s stock valued at $165,120,000 after purchasing an additional 318,698 shares during the last quarter. Palogic Value Management L.P. raised its holdings in shares of Docusign by 2.2% in the first quarter. Palogic Value Management L.P. now owns 5,438 shares of the company’s stock valued at $443,000 after purchasing an additional 117 shares during the last quarter. Finally, Empowered Funds LLC raised its holdings in shares of Docusign by 270.1% in the first quarter. Empowered Funds LLC now owns 104,485 shares of the company’s stock valued at $8,505,000 after purchasing an additional 76,255 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Insider Buying and Selling at Docusign

In other news, Director Anna Marrs sold 728 shares of the company’s stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $80.30, for a total transaction of $58,458.40. Following the sale, the director directly owned 10,799 shares of the company’s stock, valued at $867,159.70. This represents a 6.32% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Peter Solvik sold 15,000 shares of the company’s stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $81.48, for a total value of $1,222,200.00. Following the sale, the director directly owned 135,253 shares in the company, valued at $11,020,414.44. This trade represents a 9.98% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 82,533 shares of company stock worth $6,598,028. Company insiders own 1.01% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on DOCU. JPMorgan Chase & Co. raised their price objective on shares of Docusign from $77.00 to $80.00 and gave the stock a “neutral” rating in a report on Friday, September 5th. Wells Fargo & Company raised their price objective on shares of Docusign from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Friday, September 5th. Citigroup raised their target price on shares of Docusign from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Thursday, September 4th. Royal Bank Of Canada lifted their price target on shares of Docusign from $90.00 to $95.00 and gave the stock a “sector perform” rating in a research note on Friday, September 5th. Finally, Morgan Stanley lifted their price target on shares of Docusign from $86.00 to $90.00 and gave the stock an “equal weight” rating in a research note on Monday, September 8th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fourteen have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $94.14.

Docusign Stock Up 0.6%

Docusign stock opened at $85.01 on Friday. The business has a 50-day simple moving average of $76.17 and a two-hundred day simple moving average of $79.28. The company has a market cap of $17.10 billion, a P/E ratio of 63.92, a P/E/G ratio of 4.43 and a beta of 1.02. Docusign Inc. has a 52-week low of $56.70 and a 52-week high of $107.86.

Docusign (NASDAQ:DOCU) last posted its quarterly earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.08. The business had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The firm’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.97 EPS. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Research analysts anticipate that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign announced that its board has authorized a stock buyback plan on Thursday, June 5th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 6.6% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board believes its stock is undervalued.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.